Breakthrough in Cancer Gene Therapy: Researchers Develop Enhanced Nanocarriers for Targeted Treatment

Strategic Insights -

Researchers from Iran University of Science and Technology have made a significant breakthrough in cancer gene therapy by developing enhanced nanocarriers that improve the delivery of chemotherapy and gene therapy. According to a new study published in the journal Nano Materials Science, the researchers used calcium-doped metal-organic frameworks as a nanocarrier platform to co-deliver doxorubicin and plasmid CRISPR to cancer cells. The results showed a significant rise in cell death and decreased targeted gene expression.

Key Takeaways:

  • Researchers from Iran University of Science and Technology developed enhanced nanocarriers using calcium-doped metal-organic frameworks to improve the delivery of chemotherapy and gene therapy.
  • The nanocarriers significantly improved the uptake of doxorubicin and plasmid CRISPR by cancer cells, leading to a significant rise in cell death and decreased targeted gene expression.
  • The study concluded that the co-delivery of doxorubicin and pCRISPR with Ca-doped MOF nanocarriers resulted in improved anticancer efficiency.
  • The research team included Bahareh Farasati Far, Mohammad Reza Naimi-Jamal, Sepideh Ahmadi, and Navid Rabiee.
  • The study aimed to address the challenges associated with low therapeutic efficacy and off-target effects of cancer treatments.
  • The findings of the study provide new insights into the development of targeted cancer therapies.

Statistics:

  • The study was published in the journal Nano Materials Science, Volume 7, Issue 5, pages 627-642, in 2025.
  • The research was conducted by the Research Laboratory of Green Organic Synthesis and Polymers at Iran University of Science and Technology.
  • The study showed a significant rise in cell death, with a percentage increase not specified in the original text.